| Date |
Research Question / Title |
Unique ID |
Research Team |
|
June 12, 2020
|
How are Hutterite colonies responding to and coping with COVID-19 prevention and outbreaks?
|
PH061201 RR
|
Public Health
|
|
January 19, 2021
|
How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models?
|
PH011401 RR
|
Public Health
|
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
|
January 24, 2021
|
How safe are the Pfizer and Moderna vaccinations?
|
EOC011901 RR
|
EOC
|
|
October 29, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 RR
|
EOC
|
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
|
June 20, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v002 RR
|
Epidemiology & Modelling
|
|
October 19, 2020
|
What are the age restrictions for healthcare workers/volunteers?
|
EOC100801 RR
|
EOC
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
September 17, 2020
|
What evidence is there to support medical exemptions for mask wearing?
|
EOC091101 RR
|
EOC
|
|
April 25, 2020
|
What frequency of repeat population screening will be required?
|
LAB042202 RR
|
Laboratory
|
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR
|
Infectious Disease
|
|
February 10, 2022
|
What is the (case) definition of hospitalization for COVID-19 in similar jurisdictions?
|
CAC220101 RR
|
Clinical/Acute Care
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
